Hamid S, Umar M, Alam A, Siddiqui A, Qureshi H, Butt J: PSG consensus statement on management of hepatitis C virus infection--2003. J Pak Med Assoc. 2004, 54 (3): 146-150.
CAS
PubMed
Google Scholar
Pearlman BL: Hepatitis C infection: a clinical review. South Med J. 2004, 97 (4): 364-73;. 10.1097/01.SMJ.0000118903.35704.30.
Article
PubMed
Google Scholar
Schuppan D, Krebs A, Bauer M, Hahn EG: Hepatitis C and liver fibrosis. Cell Death Differ. 2003, 10 Suppl 1: S59-67. 10.1038/sj.cdd.4401163.
Article
CAS
PubMed
Google Scholar
Farinati F, Cardin R, D'Errico A, De Maria N, Naccarato R, Cecchetto A, Grigioni W: Hepatocyte proliferative activity in chronic liver damage as assessed by the monoclonal antibody MIB1 Ki67 in archival material: the role of etiology, disease activity, iron, and lipid peroxidation. Hepatology. 1996, 23 (6): 1468-1475. 10.1002/hep.510230625.
Article
CAS
PubMed
Google Scholar
Freeman A, Hamid S, Morris L, Vowler S, Rushbrook S, Wight DG, Coleman N, Alexander GJ: Improved detection of hepatocyte proliferation using antibody to the pre-replication complex: an association with hepatic fibrosis and viral replication in chronic hepatitis C virus infection. J Viral Hepat. 2003, 10 (5): 345-350. 10.1046/j.1365-2893.2003.00454.x.
Article
CAS
PubMed
Google Scholar
Lake-Bakaar G, Mazzoccoli V, Ruffini L: Digital image analysis of the distribution of proliferating cell nuclear antigen in hepatitis C virus-related chronic hepatitis, cirrhosis, and hepatocellular carcinoma. Dig Dis Sci. 2002, 47 (7): 1644-1648. 10.1023/A:1015800126283.
Article
PubMed
Google Scholar
Sherr CJ: The Pezcoller lecture: cancer cell cycles revisited. Cancer Res. 2000, 60 (14): 3689-3695.
CAS
PubMed
Google Scholar
Malumbres M, Barbacid M: To cycle or not to cycle: a critical decision in cancer. Nat Rev Cancer. 2001, 1 (3): 222-231. 10.1038/35106065.
Article
CAS
PubMed
Google Scholar
Cox LS: Multiple pathways control cell growth and transformation: overlapping and independent activities of p53 and p21Cip1/WAF1/Sdi1. J Pathol. 1997, 183 (2): 134-140. 10.1002/(SICI)1096-9896(199710)183:2<134::AID-PATH960>3.0.CO;2-D.
Article
CAS
PubMed
Google Scholar
Datto MB, Li Y, Panus JF, Howe DJ, Xiong Y, Wang XF: Transforming growth factor beta induces the cyclin-dependent kinase inhibitor p21 through a p53-independent mechanism. Proc Natl Acad Sci U S A. 1995, 92 (12): 5545-5549. 10.1073/pnas.92.12.5545.
Article
PubMed Central
CAS
PubMed
Google Scholar
Nguyen H, Mudryj M, Guadalupe M, Dandekar S: Hepatitis C virus core protein expression leads to biphasic regulation of the p21 cdk inhibitor and modulation of hepatocyte cell cycle. Virology. 2003, 312 (1): 245-253. 10.1016/S0042-6822(03)00209-5.
Article
CAS
PubMed
Google Scholar
Kwun HJ, Jung EY, Ahn JY, Lee MN, Jang KL: p53-dependent transcriptional repression of p21(waf1) by hepatitis C virus NS3. J Gen Virol. 2001, 82 (Pt 9): 2235-2241.
Article
CAS
PubMed
Google Scholar
Miyashita T, Krajewski S, Krajewska M, Wang HG, Lin HK, Liebermann DA, Hoffman B, Reed JC: Tumor suppressor p53 is a regulator of bcl-2 and bax gene expression in vitro and in vivo. Oncogene. 1994, 9 (6): 1799-1805.
CAS
PubMed
Google Scholar
Ohkawa K, Ishida H, Nakanishi F, Hosui A, Ueda K, Takehara T, Hori M, Hayashi N: Hepatitis C virus core functions as a suppressor of cyclin-dependent kinase-activating kinase and impairs cell cycle progression. J Biol Chem. 2004, 279 (12): 11719-11726. 10.1074/jbc.M308560200.
Article
CAS
PubMed
Google Scholar
Yang XJ, Liu J, Ye L, Liao QJ, Wu JG, Gao JR, She YL, Wu ZH, Ye LB: HCV NS2 protein inhibits cell proliferation and induces cell cycle arrest in the S-phase in mammalian cells through down-regulation of cyclin A expression. Virus Res. 2006, 121 (2): 134-143. 10.1016/j.virusres.2006.02.004.
Article
CAS
PubMed
Google Scholar
Werling K, Szentirmay Z, Szepesi A, Schaff Z, Szalay F, Szabo Z, Telegdy L, David K, Stotz G, Tulassay Z: Hepatocyte proliferation and cell cycle phase fractions in chronic viral hepatitis C by image analysis method. Eur J Gastroenterol Hepatol. 2001, 13 (5): 489-493. 10.1097/00042737-200105000-00005.
Article
CAS
PubMed
Google Scholar
Calabrese F, Pontisso P, Pettenazzo E, Benvegnu L, Vario A, Chemello L, Alberti A, Valente M: Liver cell apoptosis in chronic hepatitis C correlates with histological but not biochemical activity or serum HCV-RNA levels. Hepatology. 2000, 31 (5): 1153-1159. 10.1053/he.2000.7123.
Article
CAS
PubMed
Google Scholar
Marshall A, Rushbrook S, Davies SE, Morris LS, Scott IS, Vowler SL, Coleman N, Alexander G: Relation between hepatocyte G1 arrest, impaired hepatic regeneration, and fibrosis in chronic hepatitis C virus infection. Gastroenterology. 2005, 128 (1): 33-42. 10.1053/j.gastro.2004.09.076.
Article
PubMed
Google Scholar
Funakoshi F MT: Proliferative capability of hepatocytes and expression of G1-related cell cycle molecules in the development of liver cirrhosis in rats. Intern J Mol Med. 2004, 13: 779-787.
Google Scholar
Rubbia-Brandt L, Quadri R, Abid K, Giostra E, Male PJ, Mentha G, Spahr L, Zarski JP, Borisch B, Hadengue A, Negro F: Hepatocyte steatosis is a cytopathic effect of hepatitis C virus genotype 3. J Hepatol. 2000, 33 (1): 106-115. 10.1016/S0168-8278(00)80166-X.
Article
CAS
PubMed
Google Scholar
Stoeber K, Tlsty TD, Happerfield L, Thomas GA, Romanov S, Bobrow L, Williams ED, Williams GH: DNA replication licensing and human cell proliferation. J Cell Sci. 2001, 114 (Pt 11): 2027-2041.
CAS
PubMed
Google Scholar
Callea F, Brisigotti M, Fabbretti G, Sciot R, Van Eyken P, Favret M: Cirrhosis of the liver. A regenerative process. Dig Dis Sci. 1991, 36 (9): 1287-1293. 10.1007/BF01307524.
Article
CAS
PubMed
Google Scholar
Delhaye M, Louis H, Degraef C, Le Moine O, Deviere J, Peny MO, Adler M, Galand P: Hepatocyte proliferative activity in human liver cirrhosis. J Hepatol. 1999, 30 (3): 461-471. 10.1016/S0168-8278(99)80106-8.
Article
CAS
PubMed
Google Scholar
Clouston AD, Powell EE, Walsh MJ, Richardson MM, Demetris AJ, Jonsson JR: Fibrosis correlates with a ductular reaction in hepatitis C: roles of impaired replication, progenitor cells and steatosis. Hepatology. 2005, 41 (4): 809-818. 10.1002/hep.20650.
Article
CAS
PubMed
Google Scholar
Russo T, Zambrano N, Esposito F, Ammendola R, Cimino F, Fiscella M, Jackman J, O'Connor PM, Anderson CW, Appella E: A p53-independent pathway for activation of WAF1/CIP1 expression following oxidative stress. J Biol Chem. 1995, 270 (49): 29386-29391. 10.1074/jbc.270.49.29386.
Article
CAS
PubMed
Google Scholar
Arima N, Kao CY, Licht T, Padmanabhan R, Sasaguri Y, Padmanabhan R: Modulation of cell growth by the hepatitis C virus nonstructural protein NS5A. J Biol Chem. 2001, 276 (16): 12675-12684. 10.1074/jbc.M008329200.
Article
CAS
PubMed
Google Scholar
Papakyriakou P, Tzardi M, Valatas V, Kanavaros P, Karydi E, Notas G, Xidakis C, Kouroumalis E: Apoptosis and apoptosis related proteins in chronic viral liver disease. Apoptosis. 2002, 7 (2): 133-141. 10.1023/A:1014472430976.
Article
CAS
PubMed
Google Scholar
Staib F, Robles AI, Varticovski L, Wang XW, Zeeberg BR, Sirotin M, Zhurkin VB, Hofseth LJ, Hussain SP, Weinstein JN, Galle PR, Harris CC: The p53 tumor suppressor network is a key responder to microenvironmental components of chronic inflammatory stress. Cancer Res. 2005, 65 (22): 10255-10264. 10.1158/0008-5472.CAN-05-1714.
Article
PubMed Central
CAS
PubMed
Google Scholar
Goodman JE, Hofseth LJ, Hussain SP, Harris CC: Nitric oxide and p53 in cancer-prone chronic inflammation and oxyradical overload disease. Environ Mol Mutagen. 2004, 44 (1): 3-9. 10.1002/em.20024.
Article
CAS
PubMed
Google Scholar
Schafer T, Scheuer C, Roemer K, Menger MD, Vollmar B: Inhibition of p53 protects liver tissue against endotoxin-induced apoptotic and necrotic cell death. Faseb J. 2003, 17 (6): 660-667. 10.1096/fj.02-0774com.
Article
CAS
PubMed
Google Scholar
Choi J, Ou JH: Mechanisms of liver injury. III. Oxidative stress in the pathogenesis of hepatitis C virus. Am J Physiol Gastrointest Liver Physiol. 2006, 290 (5): G847-51. 10.1152/ajpgi.00522.2005.
Article
CAS
PubMed
Google Scholar
Helton ES, Chen X: p53 modulation of the DNA damage response. J Cell Biochem. 2007, 100 (4): 883-896. 10.1002/jcb.21091.
Article
CAS
PubMed
Google Scholar
Stepniak E, Ricci R, Eferl R, Sumara G, Sumara I, Rath M, Hui L, Wagner EF: c-Jun/AP-1 controls liver regeneration by repressing p53/p21 and p38 MAPK activity. Genes Dev. 2006, 20 (16): 2306-2314. 10.1101/gad.390506.
Article
PubMed Central
CAS
PubMed
Google Scholar
Fischer R, Baumert T, Blum HE: Hepatitis C virus infection and apoptosis. World J Gastroenterol. 2007, 13 (36): 4865-4872.
Article
PubMed Central
CAS
PubMed
Google Scholar
Fan G, Ma X, Wong PY, Rodrigues CM, Steer CJ: p53 dephosphorylation and p21(Cip1/Waf1) translocation correlate with caspase-3 activation in TGF-beta1-induced apoptosis of HuH-7 cells. Apoptosis. 2004, 9 (2): 211-221. 10.1023/B:APPT.0000018803.11260.02.
Article
CAS
PubMed
Google Scholar
Jin YH, Yoo KJ, Lee YH, Lee SK: Caspase 3-mediated cleavage of p21WAF1/CIP1 associated with the cyclin A-cyclin-dependent kinase 2 complex is a prerequisite for apoptosis in SK-HEP-1 cells. J Biol Chem. 2000, 275 (39): 30256-30263. 10.1074/jbc.M001902200.
Article
CAS
PubMed
Google Scholar
Levkau B, Koyama H, Raines EW, Clurman BE, Herren B, Orth K, Roberts JM, Ross R: Cleavage of p21Cip1/Waf1 and p27Kip1 mediates apoptosis in endothelial cells through activation of Cdk2: role of a caspase cascade. Mol Cell. 1998, 1 (4): 553-563. 10.1016/S1097-2765(00)80055-6.
Article
CAS
PubMed
Google Scholar
Bantel H, Lugering A, Poremba C, Lugering N, Held J, Domschke W, Schulze-Osthoff K: Caspase activation correlates with the degree of inflammatory liver injury in chronic hepatitis C virus infection. Hepatology. 2001, 34 (4 Pt 1): 758-767. 10.1053/jhep.2001.28229.
Article
CAS
PubMed
Google Scholar
Batts KP, Ludwig J: Chronic hepatitis. An update on terminology and reporting. Am J Surg Pathol. 1995, 19 (12): 1409-1417.
Article
CAS
PubMed
Google Scholar
Brunt EM, Janney CG, Di Bisceglie AM, Neuschwander-Tetri BA, Bacon BR: Nonalcoholic steatohepatitis: a proposal for grading and staging the histological lesions. Am J Gastroenterol. 1999, 94 (9): 2467-2474. 10.1111/j.1572-0241.1999.01377.x.
Article
CAS
PubMed
Google Scholar